These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 29256112

  • 1. Sensitivity analyses of four systemic lupus erythematosus disease activity indices in predicting the treatment changes in consecutive visits: a longitudinal study.
    Fatemi A, Raeisi A, Sayedbonakdar Z, Smiley A.
    Clin Rheumatol; 2018 Apr; 37(4):955-962. PubMed ID: 29256112
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Responsiveness of British Isles Lupus Assessment Group 2004 Index, Systemic Lupus Erythematosus Disease Activity Index 2000, and British Isles Lupus Assessment Group 2004 Systems Tally.
    Yee CS, Gordon C, Isenberg DA, Griffiths B, Teh LS, Bruce IN, Ahmad Y, Rahman A, Prabu A, Akil M, McHugh N, Edwards CJ, D'Cruz D, Khamashta MA, Farewell VT.
    Arthritis Care Res (Hoboken); 2022 Oct; 74(10):1623-1630. PubMed ID: 33787088
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM, Marx AS, Barry NN.
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [Abstract] [Full Text] [Related]

  • 4. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO, Corrente JE, Saad-Magalhães C.
    Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
    [Abstract] [Full Text] [Related]

  • 5. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients.
    Jesus D, Rodrigues M, Matos A, Henriques C, Pereira da Silva JA, Inês LS.
    Lupus; 2019 Apr; 28(5):607-612. PubMed ID: 30895904
    [Abstract] [Full Text] [Related]

  • 6. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA, Canti V, Moiola L, Magnoni M, Rovere-Querini P, Coletto LA, Dagna L, Manfredi AA, Bozzolo EP.
    Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
    Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O.
    J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
    [Abstract] [Full Text] [Related]

  • 8. British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus.
    Yee CS, Farewell V, Isenberg DA, Rahman A, Teh LS, Griffiths B, Bruce IN, Ahmad Y, Prabu A, Akil M, McHugh N, D'Cruz D, Khamashta MA, Maddison P, Gordon C.
    Arthritis Rheum; 2007 Dec; 56(12):4113-9. PubMed ID: 18050213
    [Abstract] [Full Text] [Related]

  • 9. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z, Gladman DD, Ibañez D, Taghavi-Zadeh S, Urowitz MB.
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [Abstract] [Full Text] [Related]

  • 10. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
    Nordin F, Shaharir SS, Abdul Wahab A, Mustafar R, Abdul Gafor AH, Mohamed Said MS, Rajalingham S, Shah SA.
    Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
    [Abstract] [Full Text] [Related]

  • 11. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG, Vilá LM, McGwin G, Sanchez ML, Reveille JD, Alarcón GS.
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [Abstract] [Full Text] [Related]

  • 12. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD, Castrejón I, Pincus T.
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [Abstract] [Full Text] [Related]

  • 13. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
    Jesus D, Matos A, Henriques C, Zen M, Larosa M, Iaccarino L, Da Silva JAP, Doria A, Inês LS.
    Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
    [Abstract] [Full Text] [Related]

  • 14. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).
    Romero-Diaz J, Isenberg D, Ramsey-Goldman R.
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11(0 11):S37-46. PubMed ID: 22588757
    [No Abstract] [Full Text] [Related]

  • 15. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000.
    Yee CS, Isenberg DA, Prabu A, Sokoll K, Teh LS, Rahman A, Bruce IN, Griffiths B, Akil M, McHugh N, D'Cruz D, Khamashta MA, Maddison P, Zoma A, Gordon C.
    Ann Rheum Dis; 2008 Jun; 67(6):873-6. PubMed ID: 17519277
    [Abstract] [Full Text] [Related]

  • 16. The rating scale preference measure as an evaluative measure in systemic lupus erythematosus.
    Ward MM, Marx AS, Barry NN.
    Lupus; 2000 Jun; 9(9):696-701. PubMed ID: 11199925
    [Abstract] [Full Text] [Related]

  • 17. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I, Tani C, Jolly M, Huang A, Mosca M.
    Clin Exp Rheumatol; 2014 Jun; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [Abstract] [Full Text] [Related]

  • 18. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
    Brunner HI, Silverman ED, Bombardier C, Feldman BM.
    Arthritis Rheum; 2003 Jun 15; 49(3):335-41. PubMed ID: 12794788
    [Abstract] [Full Text] [Related]

  • 19. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
    Wollaston SJ, Farewell VT, Isenberg DA, Gordon C, Merrill JT, Petri MA, Kalunian KC, Systemic Lupus International Collaborating Clinics (SLICC).
    J Rheumatol; 2004 Dec 15; 31(12):2390-4. PubMed ID: 15570639
    [Abstract] [Full Text] [Related]

  • 20. Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review.
    Castrejón I, Rúa-Figueroa I, Rosario MP, Carmona L.
    Reumatol Clin; 2014 Dec 15; 10(5):309-20. PubMed ID: 25022441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.